Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0460

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 80425-0460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine HCl Er 15mg Capsule #30 (Cyclobenzaprine HCl Er 15mg 80425 0460 01)

The label for Cyclobenzaprine Hydrochloride 15 mg extended-release capsules, labeled as #30 count. It shows packaging and storage information from Advanced Rx of Tennessee, LLC, Nashville, TN. The label includes NDC numbers, lot number placeholder, an expiration date of 9/1/2026, and a barcode. The product is prescription only.*

FDA Label Image

Cyclobenzaprine HCl Er 15mg Capsule #60 (Cyclobenzaprine HCl Er 15mg 80425 0460 02)

Label for Cyclobenzaprine Hydrochloride extended release 15 mg capsule. The label includes the product name, strength, dosage form, and NDC number 80425-0460. It shows storage instructions at 20°-25°C and contains a caution about federal laws regarding drug transfer. The label also features barcodes, lot number, expiration date of 9/1/2026, and mentions Advanced Rx of Tennessee, LLC as the packer and TWI Pharmaceutical as the manufacturer.*

FDA Label Image

Cyclobenzaprine HCl Er 15mg Capsule #90 (Cyclobenzaprine HCl Er 15mg 80425 0460 03)

Label for Cyclobenzaprine Hydrochloride ER 15 mg extended release capsule. The label shows it is packed by Advanced Rx of Tennessee, LLC, and includes comparison information to AMRIX with source NDC codes. The label indicates prescription use with lot and expiration date fields.*

FDA Label Image

Structural Formula (Image 1)

Chemical structure diagram of Cyclobenzaprine Hydrochloride showing its molecular framework and associated hydrochloride component. The structure includes fused rings and side chains characteristic of the active ingredient Cyclobenzaprine Hydrochloride.*

FDA Label Image

Image (Image 2)

An illustration showing a spoon containing a small amount of creamy or semi-solid substance, possibly representing a dose or form of medication. The spoon is depicted in a simple black line drawing on a white background.*

FDA Label Image

Image (Image 3)

An instructional illustration showing a hand holding a capsule marked with a 'TOP' indicator. The image demonstrates how to properly position the capsule, likely for identification or administration purposes.*

FDA Label Image

Image (Image 4)

FDA Label Image

Image (Image 5)

Illustration showing a hand opening a capsule and emptying its contents, represented as small beads, onto a spoon.*

FDA Label Image

Image (Image 6)

An instructional illustration showing a woman in profile holding a spoon with medication, depicting the action of taking an oral drug dose. The woman appears to be about to ingest the medication from the spoon, demonstrating oral administration.*

FDA Label Image

Image (Image 7)

An illustration showing a person drinking from a glass of water. The image likely depicts how to take oral medication by swallowing it with water.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.